These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34002238)

  • 1. Post-COVID-19 pulmonary fibrosis.
    Farooq S; Han S; Mohammad SA; Ammar H
    QJM; 2021 Nov; 114(9):655-656. PubMed ID: 34002238
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrotic Interstitial Lung Abnormalities at 1-year Follow-up CT after Severe COVID-19.
    Han X; Fan Y; Alwalid O; Zhang X; Jia X; Zheng Y; Shi H
    Radiology; 2021 Dec; 301(3):E438-E440. PubMed ID: 34313470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histolo-radiological dissociation in pulmonary fibrosis secondary to SARS-CoV-2 infection.
    Peiro Chamarro M; Ruiz de Gopegui Miguelena P; Sampedro Martín I; Callau Calvo A; Martínez Lamazares MT; Fuertes Schott C
    Med Intensiva (Engl Ed); 2021 Nov; 45(8):e34-e36. PubMed ID: 34454895
    [No Abstract]   [Full Text] [Related]  

  • 4. Exercise-based pulmonary rehabilitation for a post-COVID-19 pulmonary fibrosis patient: A case report.
    Choi K; Kim M; Lee SM; Kim J
    Medicine (Baltimore); 2021 Nov; 100(47):e27980. PubMed ID: 34964792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Management of Pulmonary Fibrosis in COVID-19.
    Rumende CM; Susanto EC; Sitorus TP
    Acta Med Indones; 2021 Apr; 53(2):233-241. PubMed ID: 34251354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequelae of COVID-19 pneumonia: Is it correct to label everything as post-COVID lung fibrosis?
    Garg M; Maralakunte M; Dhooria S
    J Postgrad Med; 2021; 67(4):224-227. PubMed ID: 34845890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial lung abnormalities and pulmonary fibrosis in COVID-19 patients: a short-term follow-up case series.
    Gulati A; Lakhani P
    Clin Imaging; 2021 Sep; 77():180-186. PubMed ID: 33836413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial.
    Lu ZH; Yang CL; Yang GG; Pan WX; Tian LG; Zheng JX; Lv S; Zhang SY; Zheng PY; Zhang SX
    Infect Dis Poverty; 2021 Mar; 10(1):31. PubMed ID: 33731163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal changes in computed tomography of COVID-19 pneumonia with perilobular fibrosis.
    Ng FH; Li SK; Lee YC; Ma JKF
    Hong Kong Med J; 2020 Jun; 26(3):250.e1-251.e2. PubMed ID: 32362587
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of lung volume loss with 3D CT volumetry in COVID-19 patients.
    Savaş R; Öz Özcan A
    Diagn Interv Radiol; 2021 Jan; 27(1):155-156. PubMed ID: 32876572
    [No Abstract]   [Full Text] [Related]  

  • 11. Lung Fibrosis Sequelae After Recovery from COVID-19 Infection.
    Susanto AD; Triyoga PA; Isbaniah F; Fairuz A; Cendikiawan H; Zaron F; Aryanti I; Irbah SN; Hidayat M
    J Infect Dev Ctries; 2021 Mar; 15(3):360-365. PubMed ID: 33839710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary fibrosis secondary to COVID-19: a narrative review.
    Tanni SE; Fabro AT; de Albuquerque A; Ferreira EVM; Verrastro CGY; Sawamura MVY; Ribeiro SM; Baldi BG
    Expert Rev Respir Med; 2021 Jun; 15(6):791-803. PubMed ID: 33902377
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge.
    Wei J; Yang H; Lei P; Fan B; Qiu Y; Zeng B; Yu P; Lv J; Jian Y; Wan C
    J Xray Sci Technol; 2020; 28(3):383-389. PubMed ID: 32474479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of pulmonary residuals as one of the sequelae of COVID-19 and it's predictors among moderate and severe cases.
    Abdel-Hamid HM; Rizk HI; Magdy S
    Indian J Tuberc; 2021 Oct; 68(4):450-456. PubMed ID: 34752312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung Fibrosis Following Acute Covid-19 Infection in an Infant.
    Rokaiyya A; Koushwambi K; Satyabrata RC; Mihir S
    Indian J Pediatr; 2022 Jul; 89(7):728. PubMed ID: 35275339
    [No Abstract]   [Full Text] [Related]  

  • 16. Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients.
    Hu ZJ; Xu J; Yin JM; Li L; Hou W; Zhang LL; Zhou Z; Yu YZ; Li HJ; Feng YM; Jin RH
    Front Immunol; 2020; 11():585647. PubMed ID: 33133104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
    Delpino MV; Quarleri J
    Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment.
    Rumende CM
    Acta Med Indones; 2021 Apr; 53(2):141-142. PubMed ID: 34251340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis.
    DiNicolantonio JJ; McCarty MF; Barroso-Aranda J; Assanga S; Lujan LML; O'Keefe JH
    Open Heart; 2021 Apr; 8(1):. PubMed ID: 33879509
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe COVID-19 Pneumonia of Single Transplant Lung Sparing Native Fibrotic Lung.
    Shahrouki P; Fishbein MC; Bedayat A
    Transplantation; 2022 Jan; 106(1):e105-e106. PubMed ID: 34699458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.